Policy Statement of the Magnaporthe grisea Advisory Committee to the Fungal Genetics Stock Center

 

 

The Magnaporthe scientific community members who were present at the 19th Fungal Genetics Conference at Asilomar California met on March 22nd to discuss establishing a link with the Fungal Genetics Stock Center (FGSC) at the University of Kansas Medical Center.  it was agreed that the FGSC would be the best place to function as a central clearinghouse for M. grisea genetic materials.  At this meeting, a committee was selected to advise the FGSC about decisions regarding what strains, DNA clones and recombinant libraries should be stored and distributed by the FGSC. 

 

The following policy is proposed to begin the process of strain, clone and library depostion at the FGSC. 

 

The M. grisea advisory committee agrees:

 

1. To write grants to attempt to secure support for a half-time technician to work at the FGSC to assist in cataloging, maintenance and distribution of Magnaporthe materials. 

 

2.  To select a site for storing a back-up collection of materials that will be maintained by the FGSC.

 

3.  To advise the FGSC regarding all requests by researchers for deposition of materials into the FGSC.

 

 

The M. grisea advisory committee proposes the following guidelines to begin the collection, storage and distribution of M. grisea materials by the FGSC.

 

TO BE DEPOSITED INTO THE FGSC

 

I.  FUNGAL STRAINS

 

A.        All field isolates that are listed in publications.

           

            These will be listed as to collection site and the host plant species from which each strain was isolated.

 

B.         All genetic mutants and the strains from which they were derived, that are listed in publications.

            All other genetic mutants that researchers are willing to submit to FGSC.

 

C.        RFLP mapping parental and progeny strains.

 

D.        All other published strains such as those used in breeding studies for strain development, for chromosome analyses or for gene segregation studies.

 

[E.        (Transformed strains)  Need to develop a policy about such strains. Currently it is not possible for FGSC to collect transformed strains unless APHIS is willing to grant them a general approval for all such strains]

 

II.  CLONE DNAs

 

            A.  All published clones.

 

            B.  Published vectors that will be of general utility for the community.

 

III.  DNA LIBRARIES

 

A.        For ordered libraries, at most 2 BAC libraries and 2 to 3 cosmid libraries will be stored by the FGSC.  Unordered libraries can be stored also

 

B.         Lambda libraries:  All published libraries

 

C.        cDNA libraries:  All published libraries